Array BioPharma gets FDA nod for melanoma combo treatment
(Reuters) - The U.S. Food and Drug Administration said on Wednesday it approved Array BioPharma Inc's oral combination treatment for use in patients with the deadliest form of skin cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Health | Melanoma | Oral Cancer | Skin | Skin Cancer